Trial intelligence / Profile preview

IV Pulse vs Oral Steroids for Infantile Hemangiomas

NCT00312520Phase 3Completed

Sponsor
SickKids
Start
Jul 2002
Primary completion
Jun 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of methylprednisolone in hemangioma (2 arms), sponsored by SickKids. Primary endpoint: Percent improvement in the appearance of hemangioma. Started Jul 2002; status: completed.

02

Drugs

methylprednisolone
03

Conditions

hemangioma

Beyond the preview

Go deeper on NCT00312520.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00312520.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call